Bio Essence Corp SEC filings BIOE
Bio Essence Corp has 87 filings in SEC EDGAR's recent list, going back to Nov 16, 2017. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (officer or director change, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| QUALIF | Filing | Jan 5, 2026 | — |
| 1-A | Filing | Oct 17, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2024 | — |
| NT 10-Q | Notification of late filing | Aug 14, 2024 | Jun 30, 2024 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Mar 27, 2024 | Dec 31, 2023 |
| NT 10-Q | Notification of late filing | May 13, 2022 | Mar 31, 2022 |
| NT 10-K | Filing | Mar 25, 2021 | Dec 31, 2020 |
| 8-A12G | Form 8-a12g | Mar 25, 2021 | — |
| EFFECT | Filing | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 22, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Mar 27, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2020 | — |
| CORRESP | Letter to the SEC | Feb 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2019 | — |
| DEL AM | Filing | Nov 5, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2019 | — |
| D | Filing | Jul 24, 2019 | — |
| D/A | Filing | Jan 3, 2018 | — |
| D | Filing | Nov 16, 2017 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BIOE (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- Irvine, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1723059
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.